INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Ginkgo biloba preparation was associated with improved cognitive function and global clinical assessment in Alzheimer disease patients.

A systematic review and meta-analysis of seven studies (N = 939) evaluated the efficacy and safety of Ginkgo biloba preparation for treating Alzheimer disease. Compared with placebo, Ginkgo biloba demonstrated benefits in cognitive function (risk ratio = 1.98, 95% confidence interval = 1.52-2.59, Z = 5.12, P < 0.001) and global clinical assessment via Clinical Global Impression Change (odds ratio = 3.119, 95% confidence interval = 2.206-4.410, Z = 6.44, P < 0.001). Adverse events were reported as mild.

Study type
Systematic review and meta-analysis
Who was studied
939 Alzheimer disease patients across 7 studies
What was measured
Cognitive function, global clinical assessment, and adverse events

THE PAPER

Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease.

Liao Z, Cheng L, Li X, Zhang M, Wang S, Huo R. Clin Neuropharmacol, 2020.

PubMed 32658034 ↗DOI 10.1097/wnf.0000000000000394 ↗

Brain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.